<DOC>
	<DOCNO>NCT00621192</DOCNO>
	<brief_summary>Meropenem antibiotic commonly use treat serious infection . Although used premature young infant , correct dose know . The purpose study determine correct dose safety meropenem treatment complicate intra-abdominal infection young baby .</brief_summary>
	<brief_title>Pharmacokinetic ( PK ) Safety Study Meropenem Young Infants With Intra-abdominal Infections</brief_title>
	<detailed_description>This study evaluate safety , tolerability Pharmacokinetics - Pharmacodynamics ( PK-PD ) meropenem infant &lt; 91 day age suspect complicated intra-abdominal infection . The specific aim trial : 1 . To characterize meropenem single-dose multiple-dose PK subject suspect complicated intra-abdominal infection . 2 . To characterize safety profile meropenem treatment suspect complicated intra-abdominal infection . 3 . To assess collected efficacy data meropenem treatment suspect complicated intra-abdominal infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Enterocolitis , Necrotizing</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<criteria>1 . Written permission parent legal guardian 2 . Age young 91 day 3 . Likely survive beyond first 48 hour enrollment 4 . Sufficient intravascular access ( either peripheral central ) receive study drug . AND ONE OF THE FOLLOWING 5 . 1 ) Physical , radiological , and/or bacteriological finding complicate intraabdominal infection . These include peritonitis , NEC ( Necrotizing Enterocolitis ) Grade II high Bell 's criterion , Hirschsprung 's disease perforation , spontaneous perforation , meconium ileus perforation , bowel obstruction perforation , evidence free peritoneal air abdominal radiograph , intestinal pneumatosis portal venous gas abdominal radiographic examination . OR 2 ) Possible NEC OR 3 ) Otherwise receive meropenem per local standard care Exclusion criterion : 1 . Renal dysfunction evidence urine output &lt; 0.5 mL/hr/kg prior 24 hour 2 . Serum creatinine &gt; 1.7 mg/dL 3 . History clinical seizure EEG ( Electroencephalogram ) confirm seizures 4 . Concomitant treatment another carbapenem ( ertapenem imipenem ) time inform consent 5 . Any condition would make subject caregiver , opinion investigator , unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>meropenem</keyword>
	<keyword>infant</keyword>
	<keyword>intra-abdominal infection</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
</DOC>